Fact CheckerSign in

NCT04688905Active, not recruiting

Diagnosing Heart Failure With Preserved Ejection Fraction in Patients With Unexplained Dyspnea (Diagnose-HFpEF)

Diagnosestellung Der Herzinsuffizienz Mit Erhaltener Ejektionsfraktion Bei Patienten Mit Unklarer Belastungsdyspnoe - Validierung Gegen Den Invasiven Goldstandard (Diagnose-HFpEF)

Source: ClinicalTrials.gov · Last updated 19 Nov 2025

Brief summary (registry, in English)

Invasive diagnosis of heart failure with preserved ejection fraction (HFpEF) in patients with unexplained dyspnea NYHA II-III compared to other diagnostic tools

Status (registry)
Active, not recruiting
Study type
Observational
Enrollment
30 (actual)
First submitted
4 Dec 2020
Start date
9 Sept 2020
Primary completion date
4 Aug 2023
Lead sponsor
University of Leipzig
NCT number
NCT04688905

What you commit to

  • Study type: Observational
  • Participants enrolled: 30
  • From 9 Sept 2020 to the primary completion date, 4 Aug 2023
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • unstable cardiac disease with acute decompensation
  • heart valve disease with medium or high grade insufficiency or stenosis
  • coronary heart disease with hemodynamically relevant coronary stenosis
  • acute or chronic cardiac inflammation (myocarditis, pericarditis)
  • former heart transplantation
  • relevant pulmonary disease (e.g. COPD) assumably causing the dyspnea

Lab values

  • documented former LVEF ≤ 40%
  • hemoglobin \< 5 mmol/l

Other

  • specific cardiomyopathia
  • FEV1/VC \< 70%
  • pregnant or nursing women
  • contraindication for one of the diagnostic tests

Who the study is looking for

  • dyspnea NYHA II-III
  • age 18-90 years
  • left ventricular ejection fraction ≥ 50%
  • ability to give informed consent

Age in the registry: 18 years to 90 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Universitatsklinikum Leipzig
Coordinator of this site? Confirm its status
LeipzigGermanyUnknown status

Related publications

This page is information, not medical advice. Discuss any trial with your doctor.